bizapediacom  human validation companiespeopleproductsservicestrademarksaddressesphone book our system has detected a high number of page requests from your ip address please prove to us that you are a human to continue using our website please send me to the search subscription offer page after i successfully answer the word challenge bizapediapro searchperform unlimited searches via ouradvanced search form withbizapedia pro searchfind out more bizapediapro databuild custom data listsfor one or many stateswith bizapedia pro datafind out more  copyright   · bizapediacom · all rights reservedblogpro searchpro apicontact usterms of useprivacy policysitemapdesktop version bizapediacom  human validation companiespeopleproductsservicestrademarksaddressesphone book our system has detected a high number of page requests from your ip address please prove to us that you are a human to continue using our website please send me to the search subscription offer page after i successfully answer the word challenge bizapediapro searchperform unlimited searches via ouradvanced search form withbizapedia pro searchfind out more bizapediapro databuild custom data listsfor one or many stateswith bizapedia pro datafind out more  copyright   · bizapediacom · all rights reservedblogpro searchpro apicontact usterms of useprivacy policysitemapdesktop version sofinnova ventures home team portfolio about news contact healthquest capital sofinnova partners investor portal partners for development equity in biotech sofinnova ventures news september   heather behanna to speak at world antimicrobial resistance congress  may   sofinnova announces the addition of industry leader alan colowick md mph to its partnership april   jim healy to speak at cancer advance boston february   charlotte shropshire to speak at superreturn us west october   sofinnova steps up october   sofinnova raises  million for oversubscribed fund x june   jim healy to speak at bio on market  political pressures portfolio news june   art krieg comes down from the mountain with a m round for checkmate pharmaceuticals march   virtual biotech antiva sets out on a big rd quest armed with a m round for an hpv therapy march   bioclin therapeutics inc raises  million in series b financing led by sofinnova ventures and ysios capital january   obseva sa announces pricing of initial public offering january   obseva expands leadership team and board of directors with industry veterans december   novartis bolsters innovative dermatology portfolio through acquisition of ziarco group limited november   galera therapeutics receives m from sofinnova ventures november   galera therapeutics expands series b to  million contact menlo park  sand hill road building  suite  menlo park ca  telephone   san diego  prospect street ocean level   la jolla ca  telephone   for inquiries please email infosofinnovacom for information about our sister firm sofinnova partners based in paris france please visit wwwsofinnovafr âšâ  sofinnova ventures inc sofinnova management vi llc  ceo founder businessman  profile directorpedianet  list of ceos founders board members and company directors sofinnova management vi llc check out list of companies and businesses related to sofinnova management vi llc find out sofinnova management vi llc address and contact details view other people related to sofinnova management vi llc  coworkers colleagues companions etc address  geary street th floor san francisco  ca companies related to sofinnova management vi llc cikcompany namepositioncompany addressanthera pharmaceuticals inc owner  industrial boulevard suite b hayward  sofinnova management vi llc on the web persons related to sofinnova management vi llc  anthera pharmaceuticals incnamepositioncityalain azanmenlo parkalain azanmenlo parkannette bianchidirector san brunoannette bianchisan brunoeric buatoismenlo parkklara dickinsonchief regulatory officer south san franciscobogdan dziurzynski haywardbogdan dziurzynskihaywardbogdan dziurzynskidirector haywardbogdan dziurzynskidirector haywardbogdan dziurzynski haywardsteven b engle san diegosteven b engleberkeleysteven b engle haywardursula fritschvp glob reg  compliance haywardbrent furseparsippanyjames healydirector menlo parkjames healy haywardjames healydirector haywardchristopher s henney seattlechristopher s henney haywardchristopher s henney haywardchristopher s henneydirector haywardcolin hislopchief medical officer haywardcolin hislopchief medical officer haywardcolin hislopchief medical officer haywardsamuel d isalynew yorksamuel d isalynew yorksamuel d isalynew yorksamuel d isalynew yorkgeorgina kilfoilsvp prod dev  project mngm haywardgeorgina kilfoilsvpproduct dev project mgmt haywardgeorgina kilfoilsvpproduct dev project mgmt haywardstephen lauvp corp  business dev haywarda rachel lehenydirector haywardmay liuprincipal accounting officer haywardchristopher p lowechief financial officer  cbo haywardchristopher p lowecfo and cbo haywardchristopher p lowecfo and cbo haywardchristopher p lowecfo and chief business officer haywardbrian mueller novatobrian muellerhaywardbrian mueller haywardbrian mueller haywarddebra odinkchief technology officer haywarddebra odinkchief technology officer haywarddebra odinkchief technology officer haywardcharles v olsonchief technology officer haywardorbimed advisors llcdirector new yorkorbimed advisors llcdirector new yorkorbimed advisors llc owner new yorkorbimed advisors llcdirector new yorkorbimed capital gp iv llcnew yorkorbimed capital gp iv llcnew yorkorbimed capital gp iv llcnew yorkjames penningtonhaywardjames e penningtonhaywardmichael powellmenlo parkphilip sager haywardphilip sager haywardphilip sager haywardalan e salzmansan brunoalan e salzmansan brunodonald j santeldirector haywardwilliam r shanahan jrchief medical officer san diegosofinnova venture affiliates vi lpmenlo parksofinnova venture partners vi gmbh  co kgmenlo parksofinnova venture partners vi l p owner san franciscosofinnova venture partners vi l p owner menlo parkdaniel k spiegelman haywarddaniel k spiegelman haywarddaniel k spiegelmandirector haywarddavid e thompsondirector haywarddavid e thompson haywarddavid e thompson haywardjohn craig thompsonpresident  ceo san diegopeter a thompsondirector haywardjoaquim triassr vp preclinical developmen haywardpaul f truexexecutive chaiman haywardpaul f truexpresident and ceo haywardpaul f truexpresident and ceo haywardpaul f truexpresident and ceo haywardpaul f truexpresident and ceo haywardvantagepoint venture associates iv llc owner san brunovantagepoint venture associates iv llc owner san brunovantagepoint venture partners iv lpsan brunovantagepoint venture partners iv lpsan brunovantagepoint venture partners iv principals fund lpsan brunovantagepoint venture partners iv principals fund lpsan brunovantagepoint venture partners iv q lpsan brunovantagepoint venture partners iv q lpsan brunozenyaku kogyo co ltdtokyosanford s zweifach haywardsanford s zweifach haywardsanford s zweifach hayward potentially same personnamecitycountrysofinnova management vi llcsan franciscocasofinnova management vi llcmenlo parkcasofinnova management vi llcmenlo parkca insider trading  mehra anand  form  sec filings home  archives  products  about  contact  faq  new user sign up  sign in form  filings insider buys significant buys penny stocksinsider buying insider sales insider buy sell ratios stock options insider tradingstock screener insider tradinggraph view insider watch sec filings insider trading  mehra anand select time period  month  months  months  months  year  years  years  years all data       google     yahoo send this page to   blog    digg    reddit    facebook    stumble    delicious enter stock ticker symbol or cik cik lookup search by company or insider name insiders might sell their shares for any number of reasons but they buy them for only one they think the price will rise  peter lynch  what is insider trading email a friend  historical filings delayed by  months new user sign up for real time data existing user sign in common stock purchase or sale transactiondate reporteddate company symbol insiderrelationship sharestraded averageprice totalamount sharesowned filing sale  pm spark therapeutics inc once mehra ananddirector    indirect view sale  pm spark therapeutics inc once mehra ananddirector    indirect view sale  pm marinus pharmaceuticals inc mrns mehra anandsofinnova venture partners vi l psofinnova venture partners vi gmbh  co kgsofinnova venture affiliates vi lpsofinnova management vi llcbuatois erichealy jamesazan alainpowell michael owner    indirect view sale  pm spark therapeutics inc once mehra ananddirector    indirect view sale  pm spark therapeutics inc once mehra ananddirector    indirect view sale  pm spark therapeutics inc once mehra ananddirector    indirect view sale  pm spark therapeutics inc once mehra ananddirector    indirect view sale  pm spark therapeutics inc once mehra ananddirector    indirect view sale  pm spark therapeutics inc once mehra ananddirector    indirect view sale  pm spark therapeutics inc once mehra ananddirector    indirect view purchase  pm aclaris therapeutics inc acrs mehra ananddirector owner    indirect view sale  pm spark therapeutics inc once mehra ananddirector    indirect view purchase  pm mirna therapeutics inc mirn sofinnova venture partners viii lpsofinnova management viii llchealy jamesakkaraju srinivasmehra anand owner    direct view purchase  pm atyr pharma inc life sofinnova venture partners ix lpsofinnova management ix llchealy jamespowell michaelmehra anand owner    direct view sale  pm aerie pharmaceuticals inc aeri mehra ananddirector    indirect view purchase  pm spark therapeutics inc once mehra ananddirector    indirect view stock options exercise award grant conversion transactiondate reporteddate exercisableexpiration company symnbol insiderrelationship sharestraded conversionprice sharesowned filing option award  pm na marinus pharmaceuticals inc mrns mehra ananddirector   direct view option award  pm na marinus pharmaceuticals inc mrns mehra ananddirector   direct view option award  pm na aclaris therapeutics inc acrs mehra ananddirector owner   direct view option award  pm na spark therapeutics inc once mehra ananddirector   direct view conversion  pm nana aclaris therapeutics inc acrs mehra ananddirector owner   indirect view conversion  pm nana aclaris therapeutics inc acrs mehra ananddirector owner   indirect view conversion  pm nana aclaris therapeutics inc acrs mehra ananddirector owner   indirect view conversion  pm nana aclaris therapeutics inc acrs mehra ananddirector owner   indirect view conversion  pm nana mirna therapeutics inc mirn sofinnova venture partners viii lpsofinnova management viii llchealy jamesakkaraju srinivasmehra anand owner   direct view conversion  pm nana mirna therapeutics inc mirn sofinnova venture partners viii lpsofinnova management viii llchealy jamesakkaraju srinivasmehra anand owner   direct view other  pm nana mirna therapeutics inc mirn sofinnova venture partners viii lpsofinnova management viii llchealy jamesakkaraju srinivasmehra anand owner   direct view conversion  pm nana mirna therapeutics inc mirn sofinnova venture partners viii lpsofinnova management viii llchealy jamesakkaraju srinivasmehra anand owner   direct view conversion  pm nana mirna therapeutics inc mirn sofinnova venture partners viii lpsofinnova management viii llchealy jamesakkaraju srinivasmehra anand owner   direct view option award  pm na marinus pharmaceuticals inc mrns mehra ananddirector owner   direct view conversion  pm nana atyr pharma inc life sofinnova venture partners ix lpsofinnova management ix llchealy jamespowell michaelmehra anand owner   direct view conversion  pm nana atyr pharma inc life sofinnova venture partners ix lpsofinnova management ix llchealy jamespowell michaelmehra anand owner   direct view exercise  pm nana aerie pharmaceuticals inc aeri mehra ananddirector   indirect view other  pm nana aerie pharmaceuticals inc aeri mehra ananddirector   indirect view exercise  pm nana aerie pharmaceuticals inc aeri mehra ananddirector   indirect view option award  pm nana aerie pharmaceuticals inc aeri mehra ananddirector   direct view option award  pm na aerie pharmaceuticals inc aeri mehra ananddirector   direct view conversion  pm nana spark therapeutics inc once mehra ananddirector   indirect view option award  pm nana spark therapeutics inc once mehra ananddirector   indirect view conversion  pm nana spark therapeutics inc once mehra ananddirector   indirect view   secformcom all rights reserved archives        fri  jul    sec is the us securities and exchange commission edgar is a trademark of the sec secformcom is not affiliated with or approved by the us securities and exchange commission sec terms of use  privacy statement  active investments portfolio  sofinnova ventures home team portfolio about news contact healthquest capital sofinnova partners investor portal active investments selected realized investments remaining it investments active investments aclaris therapeutics specialty pharmaceutical dermatology company focused on the development of novel dermatologic therapies nasdaq acrs aerie pharmaceuticals clinicalstage biotechnology company dedicated to the discovery and development of novel treatments for glaucoma nasdaq aeri alimera sciences specializes in the research development and commercialization of prescription ophthalmic pharmaceuticals nasdaq alim amarin focused on improving the treatment of cardiovascular disease the company’s cardiovascular programs capitalize on its expertise in the field of lipid science and the known therapeutic benefits of essential fatty acids in treating cardiovascular disease nasdaq amrn anthera pharmaceuticals focused on developing and commercializing products to treat serious diseases associated with inflammation including cardiovascular and autoimmune diseases nasdaq anth antiva develop creatively designed therapeutics that dramatically improve health outcomes for patients suffering from diseases caused by hpv and other viruses ascendis pharma ascendis pharma develops differentiated prodrug versions of highvalue protein drugs such as growth hormone nasdaq asnd atyr pharma focused on the discovery and clinical development of innovative medicines for patients suffering from severe rare diseases using its knowledge of physiocrine biology a newly discovered set of physiological modulators nasdaq life audentes therapeutics committed to the development and commercialization of innovative new treatments for people with serious rare diseases through the application of gene therapy technology nasdaq bold auris medical prevention or treatment of inner ear disorders for acute inner ear tinnitus and for acute inner ear hearing loss nasdaq ears bioclin therapeutics our strategy is to develop biologics for medical conditions where there has been no approved or satisfactory therapy our lead product b is a human antibody targeting fgfr fibroblast growth factor receptor  being developed as a treatment for metastatic bladder cancer and achondroplasia dwarfism catalyst biosciences creating novel catalytic biopharmaceutical products based on engineered human proteases checkmate pharmacueticals developing novel approach to specifically activating the immune system to recognize and ultimately destroy tumor cells chiasma latestage biotech developing an oral drug candidate for acromegaly nasdaq chma coherus biosciences a leading developer of highquality therapeutics with a robust pipeline of biosimilar products nasdaq chrs dauntless pharmaceuticals biopharmaceutical company focused on the development of specialty drugs edge therapuetics develops commercialize novel hospitalbased therapies capable of transforming treatment paradigms in the management of acute lifethreatening neurological conditions nasdaq edge first aid shot therapy focused on the development and commercialization of a comprehensive portfolio of otc pharmaceutical products in liquid shot format galera therapeutics galera therapeutics is a private clinicalstage biotech company focused on the development of breakthrough drugs targeting the oxygen metabolic pathways histogenics combining cell therapy and tissue engineering technologies to develop highly innovative products for tissue repair and regeneration nasdaq hsgx hyperion therapeutics focused on the development of treatments that address critical unmet needs in the areas of gastroenterology and hepatology nadsaq hptx innocoll developing and manufacturing a range of pharmaceutical products and medical devices using its proprietary collagenbased technologies nasdaq innl merus clinicalstage immunooncology company developing innovative bispecific antibody therapeutics to treat and potentially cure cancer patients mirna therapeutics developing tumor suppressor micrornas mirnas to kill cancer cells by regaining control over multiple oncogenic pathways nasdaq mirn natera develops and commercializes noninvasive methods for analyzing dna nucana developing and commercialising novel anticancer medicines including next generation nucleotide prodrugs obseva dedicated to the development of innovative drugs for women’s reproductive medicine including preterm labor ocera focused on the development of drugs to treat a broad range of gastrointestinal and liver diseases nasdaq ocrx ophthotech corporation specializing in the development of novel therapeutics to treat diseases of the eye nasdaq opht principia biopharma focused on discovering and developing firstinclass small molecule drugs within the fields of autoimmune disease and oncology that are potent and safe prothena advancing and developing novel antibodies for broad range of diseases involving protein misfolding or cell adhesion including amyloidosis nasdaq prta spark therapeutics focused on developing curative onetime gene therapy products including lead gene therapy candidate for rperelated blindness nasdaq once versartis developing therapeutics for the treatment of endocrine disorders including human growth hormones nasdaq vsar ziarco ziarco is a private clinical stage biotechnology company developing products to treat chronic inflammatory diseases with a focus on inflammatory skin disorders in particular atopic dermatitis and psoriasis these diseases impact the wellbeing of millions of children and adults globally by severely reducing quality of life zs pharma focused on the treatment of kidney and liver diseases including hyperkalemia nasdaq zsph   sofinnova ventures inc active investments portfolio news june  art krieg comes down from the mountain with a m round for checkmate pharmaceuticals march  virtual biotech antiva sets out on a big rd quest armed with a m round for an hpv therapy march  bioclin therapeutics inc raises  million in series b financing led by sofinnova ventures and ysios capital january  obseva sa announces pricing of initial public offering january  obseva expands leadership team and board of directors with industry veterans december  novartis bolsters innovative dermatology portfolio through acquisition of ziarco group limited november  galera therapeutics receives m from sofinnova ventures november  galera therapeutics expands series b to  million july  dauntless takes flight with new business model for starting biotechs sofinnova management vi llc  anthera pharmaceuticals insider transactions  tipranks go prologin  sign up follow✓get real time transactionsinsider detailssofinnova management vi llcanthera pharmaceuticals anthten percent owner not rankedsofinnova management vi llcs performancesofinnova management vi llc has not reported any informative transactions and therefore cannot be rankedhow are insiders ranked insider holdings  anthera pharmaceuticals anthmsee the top stocks by insiders  insider rolesanthera pharmaceuticals anth ten percent ownersee the top  corporate insiders  most profitable insider tradestock anthera pharmaceuticals anthtransaction type informative buydates mar    mar  gain see the latest stocks traded by insiders  sofinnova management vi llcs trading historybased on form  follow✓get real time transactionscompany nameinsider positionholding valuelast transactionlast transaction amountlast transaction dateanthanthera pharmaceuticalsten percent owneruninformative buymar  success rate on stock out of  profitable transactions on anthaverage profit on stockaverage return per transaction on anth  track record showingall transactionsinformative transactionsdatetransactionamountno of sharesprice per shareprofitform  mar   informative buy m    mar   uninformative buy m   na see all insider trading from today you may also likemeet our smart portfolio see what top analysts say about your stocksget a breakdown of the different strategies based on detected insider trading activityfind the best performing analyst in each sector follow them so you never miss a recommendationrelated linkshow can i benefit from insider trading see the top  corporate insiders go to hot stocks by insiders find which stocks insiders traded today become a tipranks memberget the best investing tips  hacks straight to your emailfree membershipsubmitinsider trading daily newsletterprofessional daytrading strategy based on predictive insider transactionsannual return learn more powered by brightscope  advisor pages  find a financial advisor or advisory firm getsearchtypedisplaynamesearchtype advisor funds firms k plans general search advisors advisory firms financial qa k plans funds search home    brightscope advisor pages    find a financial advisory firm advisor search firm search advisors by city find a financial advisory firm search firm name active firms only city state alabama alaska american samoa arizona arkansas california colorado connecticut delaware district of columbia florida georgia guam hawaii idaho illinois indiana iowa kansas kentucky louisiana maine maryland massachusetts michigan minnesota mississippi missouri montana nebraska nevada new hampshire new jersey new mexico new york north carolina north dakota northern marinara islands ohio oklahoma oregon pennsylvania puerto rico rhode island south carolina south dakota tennessee texas utah vermont virgin islands virginia washington west virginia wisconsin wyoming firm service areas financial planning estate planning comprehensive financial planning retirement planning college planning charitable planning other financial planning tax planning insurance life insurance health insurance longterm care insurance annuities property  casualty insurance business insurance other insurance pension consulting k b  defined benefit other pension consulting portfolio management individuals andor small businesses investment companies businesses or institutional clients other portfolio management accounting  tax tax advice other tax legal legal planning legal advice other legal other publication of periodicals or newsletters security ratings or pricing services market timing services selection of other advisors educational seminarsworkshops see all service areas find filters financialplanningfindfirm compensation arrangements no preference fixed fees  hourly charges  performancebased fees  none  fee only  assets under mgmt no preference   k  m  m  m  m  m  m  b  b  avg account balance no preference   k  k  k  k  m  m  m  m  m  financial advisory firm search results  results merrill lynch pierce fenner  smith incorporated ny ny  advisors  aum  b wells fargo advisors llc st louis mo  advisors  aum  b jp morgan securities llc manhattan ny  advisors  aum  b morgan stanley smith barney llc harrison ny  advisors  aum  b lpl financial llc boston ma  advisors  aum  b edward d jones  co lp des peres mo  advisors  aum  b ameriprise financial services inc minneapolis mn  advisors  aum  b ubs financial services inc weehawken nj  advisors  aum  b northwestern mutual investment servicesllc milwaukee wi  advisors charles schwab  co inc south beach ca  advisors mml investors services llc pine point ma  advisors  aum  b goldman sachs  co ny ny  advisors  aum  b strategic advisers inc boston ma  advisors  aum  b citigroup global markets inc new york ny  advisors  aum  b raymond james  associates inc st petersburg fl  advisors  aum  b      company info about us newsroom careers contact blog explore k plan ratings advisor pages fund pages financial insights faq for advisors advisor pages spyglass for enterprise beacon social facebook twitter linkedin legal privacy policy terms of use copyright   brightscope inc all rights reserved your use of this service is subject to ourterms of useandprivacy policy information is provided as is and solely for informational purposes not for investment purposes or advicebrightscope is not a fiduciary under erisa brightscope is not endorsed by or affiliated with finra brightscope  cio  fww  global custodian  investor economics  liquidmetrix  market metrics  matrix solutions  planadviser  plan for life  plansponsor  simfund  strategic insight  the trade  strategic insight inc all rights reserved no reproduction without prior authorizations sofinnova ventures  financial services firm menlo park california  brightscope advisor pages getsearchtypedisplaynamesearchtype advisor funds firms k plans back to top homefirmpagessofinnova ventures sofinnova ventures overviewarticlesholdingsassetsservicesadvisorsleadershipfees share sofinnova ventures overviewarticlesholdingsassetsservicesadvisorsleadershipfees overview description sofinnova ventures is a ria based in menlo park ca with b in aum information type ria head quarters menlo park ca  of employees  total assets  website location  sand hill rd menlo park ca   articles insights there are no insights from this firm to display at this time procter  gamble plans competitive but exposure to company stock a risk to participants brightscope editorial firm links there are no links for this firm to display at this time holdings etf holdings there is no etf holding data from this firm to display at this time assets assets last updated on march   b total assets under management na total assets under advisement  accounts m estimated average account balance services firm services there is no services data available to display at this time firm client types advisors current advisors  of advisors  there are no advisors from this firm to display at this time affiliated investment advisors and broker dealers name type total assets sofinnova bioequities gp llc   sofinnova management ix llc   sofinnova management v  llc   sofinnova management v llc   sofinnova management vi llc   sofinnova management vii llc   sofinnova management viii llc   sofinnova management x llc   sofinnova ventures verwaltungs gmbh   leadership ownership there is no ownership data available to display at this time executives and control persons name title tenure date  ownership alain louis azan shareholder and director june   to  michael frank powell shareholder director and vice president august   to  nathalie marie auber shareholder director and chief financial officer january   to  james irvin healy shareholder director and president june   to  anand no middle name mehra shareholder director and vice president may   to  hooman no middle name shahlavi shareholder secretary and general counsel february   to  james dennis brody chief compliance officer october  less than  source sec fees types of compensation arrangements percentage of assets performancebased fees other company info about us newsroom careers contact blog explore k plan ratings advisor pages fund pages financial insights faq for advisors advisor pages spyglass for enterprise beacon social facebook twitter linkedin legal privacy policy terms of use copyright   brightscope inc all rights reserved your use of this service is subject to ourterms of useandprivacy policy information is provided as is and solely for informational purposes not for investment purposes or advicebrightscope is not a fiduciary under erisa brightscope is not endorsed by or affiliated with finra brightscope  cio  fww  global custodian  investor economics  liquidmetrix  market metrics  matrix solutions  planadviser  plan for life  plansponsor  simfund  strategic insight  the trade  strategic insight inc all rights reserved no reproduction without prior authorizations sofinnova management vi llc top holdings whalewisdom search all search f filers only search sec filer search stocks only search mgmt inv cos only etfs only search active sofinnova management vi llc • menlo park ca how do i update this listing sofinnova management vi is based out of menlo park summary dg insider form  create email alert × email notification log in or signup to see more advanced email alert options such as selecting any type of sec form multiple filers or classes of filers and much more or to simply have an email sent to you whenever we receive a new f filing from sofinnova management vi llc enter your email address below and choose submit your email cancel contact info sofinnova management vi llc  sand hill road  menlo park ca     business phone  recent sec filings  filed on   filed on   filed on   filed on   filed on   filed on  schedule d and g events since  subscription required form   nonderivative insider transactions since  loading elevate your investments try it for free sofinnova ventures  financial services firm menlo park california  brightscope advisor pages getsearchtypedisplaynamesearchtype advisor funds firms k plans back to top homefirmpagessofinnova ventures sofinnova ventures overviewarticlesholdingsassetsservicesadvisorsleadershipfees share sofinnova ventures overviewarticlesholdingsassetsservicesadvisorsleadershipfees overview description sofinnova ventures is a ria based in menlo park ca with b in aum information type ria head quarters menlo park ca  of employees  total assets  website location  sand hill rd menlo park ca   articles insights there are no insights from this firm to display at this time procter  gamble plans competitive but exposure to company stock a risk to participants brightscope editorial firm links there are no links for this firm to display at this time holdings etf holdings there is no etf holding data from this firm to display at this time assets assets last updated on march   b total assets under management na total assets under advisement  accounts m estimated average account balance services firm services there is no services data available to display at this time firm client types advisors current advisors  of advisors  there are no advisors from this firm to display at this time affiliated investment advisors and broker dealers name type total assets sofinnova bioequities gp llc   sofinnova management ix llc   sofinnova management v  llc   sofinnova management v llc   sofinnova management vi llc   sofinnova management vii llc   sofinnova management viii llc   sofinnova management x llc   sofinnova ventures verwaltungs gmbh   leadership ownership there is no ownership data available to display at this time executives and control persons name title tenure date  ownership alain louis azan shareholder and director june   to  michael frank powell shareholder director and vice president august   to  nathalie marie auber shareholder director and chief financial officer january   to  james irvin healy shareholder director and president june   to  anand no middle name mehra shareholder director and vice president may   to  hooman no middle name shahlavi shareholder secretary and general counsel february   to  james dennis brody chief compliance officer october  less than  source sec fees types of compensation arrangements percentage of assets performancebased fees other company info about us newsroom careers contact blog explore k plan ratings advisor pages fund pages financial insights faq for advisors advisor pages spyglass for enterprise beacon social facebook twitter linkedin legal privacy policy terms of use copyright   brightscope inc all rights reserved your use of this service is subject to ourterms of useandprivacy policy information is provided as is and solely for informational purposes not for investment purposes or advicebrightscope is not a fiduciary under erisa brightscope is not endorsed by or affiliated with finra brightscope  cio  fww  global custodian  investor economics  liquidmetrix  market metrics  matrix solutions  planadviser  plan for life  plansponsor  simfund  strategic insight  the trade  strategic insight inc all rights reserved no reproduction without prior authorizations